Ftse Mib
33.641,96
-0,28%
DAX
18.001,60
0,54%
S&P 500
5.130,01
1,30%
NASDAQ
16.171,70
2,09%
Bitcoin
61.846,80
4,61%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Mersana Therapeutics Inc (MRSN) Mersana Therapeutics Inc (MRSN) Notizie

Mersana Therapeutics Inc

MRSN
3,465
0,105 (3,12%)
Ultimo aggiornamento: 21:29:04
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
02/5/202414:00GLOBEMersana Therapeutics to Host First Quarter 2024 Conference..
04/4/202422:30GLOBEMersana Therapeutics Announces Inducement Grants Under..
28/2/202422:08EDGAR2Form 8-K - Current report
28/2/202422:07EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/2/202422:05EDGAR2Form POS AM - Post-Effective amendments for registration..
28/2/202414:49EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28/2/202414:43EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
28/2/202413:07EDGAR2Form 8-K - Current report
28/2/202413:00GLOBEMersana Therapeutics Provides Business Update and..
27/2/202414:01GLOBEMersana Therapeutics to Present at Upcoming Investor..
21/2/202414:00GLOBEMersana Therapeutics to Host Fourth Quarter and Year End..
16/2/202422:30EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
15/2/202402:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/2/202402:43EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202415:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202414:00GLOBEMersana Therapeutics to Participate in Guggenheim’s 6th..
17/1/202423:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202423:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202403:14EDGAR2Form 144 - Report of proposed sale of securities
17/1/202403:13EDGAR2Form 144 - Report of proposed sale of securities
17/1/202403:13EDGAR2Form 144 - Report of proposed sale of securities
12/1/202422:42EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/1/202414:06EDGAR2Form 8-K - Current report
05/1/202414:01GLOBEMersana Therapeutics Announces Business Updates, Expected..
04/1/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202322:11EDGAR2Form 8-K - Current report
01/12/202322:30GLOBEMersana Therapeutics Announces Inducement Grants Under..
07/11/202314:42EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202313:18EDGAR2Form 8-K - Current report
07/11/202313:00GLOBEMersana Therapeutics Provides Business Update and Announces..
31/10/202321:30GLOBEMersana Therapeutics to Host Third Quarter 2023 Conference..
31/10/202317:59DJNMersana Therapeutics Shares Rise 8% After FDA Lifts Clinical..
31/10/202314:07DJNMersana Says FDA Lifts Clinical Hold on Gastric-Cancer..
31/10/202313:12EDGAR2Form 8-K - Current report
31/10/202313:00GLOBEMersana Therapeutics Announces FDA has Lifted Clinical Hold..
27/10/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202322:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202314:27EDGAR2Form 8-K - Current report
07/9/202323:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202323:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202323:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202323:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202323:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 3,52 Min: 3,44 Max: 3,63
Chiusura: 3,36

La tua Cronologia

NASDAQ
MRSN
Mersana Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network